New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
10:02 EDTTCO, PRGO, AGN, ACMP, BIN, TEVA, SGNT, MYL, COTY, NMBL, EGHT, TEX, O, CQP, JAH, WWAV, RGP, ACRX, AKRX, ANIP, ACTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ANI Pharmaceuticals (ANIP) initiated with a Buy at Roth Capital... AcelRx (ACRX) initiated with an Outperform at RBC Capital... Actavis (ACT) initiated with an Outperform at RBC Capital... Akorn (AKRX) initiated with an Outperform at RBC Capital... Allergan (AGN) initiated with an Outperform at RBC Capital... Cheniere Energy Partners (CQP) initiated with an Outperform at Credit Suisse... Mylan (MYL) initiated with an Outperform at RBC Capital... Perrigo (PRGO) initiated with a Top Pick at RBC Capital... Realty Income (O) initiated with an Outperform at Oppenheimer... Sagent Pharmaceuticals (SGNT) initiated with an Underperform at RBC Capital... Taubman Centers (TCO) initiated with a Perform at Oppenheimer... Terex (TEX) initiated with a Hold at Jefferies... Teva (TEVA) initiated with a Sector Perform at RBC Capital... Regency Energy Partners (RGP) reinstated with an Outperform at Credit Suisse... 8x8, Inc. (EGHT) initiated with a Buy at Needham... Progressive Waste (BIN) initiated with an Underperform at Macquarie... WhiteWave Foods (WWAV) reinstated with an Overweight at JPMorgan... Nimble Storage (NMBL) initiated with a Buy at Stifel... Access Midstream (ACMP) coverage assumed with an Outperform at Credit Suisse... Jarden (JAH) initiated with an Outperform at RBC Capital... Coty (COTY) initiated with a Sector Perform at RBC Capital.
News For ANIP;ACRX;ACT;AKRX;AGN;CQP;MYL;PRGO;O;SGNT;TCO;TEX;TEVA;RGP;EGHT;BIN;WWAV;NMBL;ACMP;JAH;COTY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
November 11, 2014
16:11 EDTTCOTaubman Centers initiated with an Outperform at Credit Suisse
Target $87.
15:46 EDTAGNPershing Square, Sachem Head build 10% stake in Zoetis, WSJ reports
Subscribe for More Information
10:20 EDTACRXHigh option volume stocks
High option volume stocks: RLGY TWC LITB SPM ACRX JWN OCR CALL CST ERIC
08:32 EDTACT, AGNValeant likely to raise offer for Allergan again, says Bernstein
Subscribe for More Information
08:16 EDTEGHT8x8, Inc. appoints Enzo Signore as Chief Marketing Officer
8x8, Inc. announced the appointment of enterprise communications industry veteran Enzo Signore as SVP and Chief Marketing Officer. Signore will report directly to 8x8 CEO Vik Verma and will be responsible for the strategy and execution of 8x8’s global marketing efforts. Signore was most recently VP of Worldwide Enterprise Solutions and Field Marketing at Avaya.
November 10, 2014
16:34 EDTACTActavis appoints Maria Teresa Hilado as CFO
Subscribe for More Information
16:16 EDTACRXAcelRx sees FY14 R&D expenses $25M-$27M
Subscribe for More Information
16:15 EDTACRXAcelRx reports Q3 EPS (13c), consensus (22c)
Reports Q3 revenue $4.83M, consensus $4.43M.
15:56 EDTTEXTerex April calls active
Subscribe for More Information
15:53 EDTPRGOCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
15:15 EDTACMPJefferies to hold a conference
2014 Global Energy Conference is being held in New York on November 11-12.
12:06 EDTWWAVDean Foods rallies after Q3 results, guidance top estimates
Shares of Dean Foods (DF), a direct-to-store distributor of dairy products, are rallying after the company’s third quarter results, as well as its fourth quarter and full year profit outlook, surpassed analysts’ consensus estimates. WHAT'S NEW: This morning, Dean Foods reported Q3 adjusted earnings per share of (3c) and revenue of $2.37B, topping analysts’ consensus estimates of (13c) and $2.35B, respectively. Chief Financial Officer Chris Bellairs noted that the company was seeing positive signs of progress which will pave the way for it to rebuild profitability in 2015 and beyond. WHAT’S NOTABLE: Looking ahead to Q4, Dean Foods forecast adjusted EPS of 5c-15c, well ahead of analysts' (2c) consensus. The company said the dairy commodity envrionment remains "challenging." The company expects raw milk costs will remain "stubbornly high" despite continued strong global production growth and waning demand, and does not see any relief until 2015. However, the company does expect significant butterfat cost declines at the end of Q4. Dean Foods said industry volumes remain "soft" and sees Q4 volumes to be down low single digits as compared to prior year, but with a continued improvement to net price realization. For FY14, adjusted EPS is seen at (16c)-(6c), also well ahead of expectations of (33c). Adjusted EBITDA for FY14 is expected to be $193M-$208M. On its earnings conference call, Dean Foods said domestic raw milk costs are likely to moderate as it exits 2014. PRICE ACTION: In early afternoon trading, Dean Foods rose $1.89 or 12.76% to $16.26 on more than twice its average daily trading volume. Despite today's advance, the shares have lost approximately 15% over the past 12 months. OTHERS TO WATCH: Other companies in the dairy product space include WhiteWave Foods (WWAV), which also reported better than expected results this morning, down 3.6%, and Lifeway Foods (LWAY), up 0.6%.
09:20 EDTWWAVOn The Fly: Pre-market Movers
Subscribe for More Information
08:46 EDTWWAVWhiteWave Foods raises low-end of FY14 EPS view to 99c-$1.00 from 98c-$1.00
Subscribe for More Information
08:44 EDTWWAVWhiteWave Foods sees Q4 EPS 26c-27c, consensus 28c
Subscribe for More Information
07:19 EDTPRGOCredit Suisse to hold a conference
Subscribe for More Information
07:12 EDTACRXAcelRx receives ISO certification of its quality management system
Subscribe for More Information
07:07 EDTWWAVWhiteWave Foods reports Q3 EPS ex-items 27c, consensus 26c
Reports Q3 revenue $857.47M, consensus $843.25M.
November 9, 2014
14:11 EDTAKRXAkorn management to meet with Needham
Subscribe for More Information
13:26 EDTAGNAckman's Allergan court win may prove costly down the road, Bloomberg says
When U.S. District Court Judge David Carter ruled on November 4 that Pershing Square can vote its 9.7% stake in Allergan (AGN) in a shareholder ballot aiming to remove Allergan directors, he also noted that there were “serious questions” regarding insider trading rules in the way Pershing Square acquired Allergan stock while preparing a bid with Valeant (VRX), says Bloomberg. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use